Home > Cashflow Statement > BAL PHARMA

BAL PHARMA
Cashflow Statement

BAL PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

BAL PHARMA Last 5 Year Cashflow Statement History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Profit Before Tax₹5.93 Cr₹5.14 Cr₹9.05 Cr₹4.75 Cr₹9.18 Cr
Adjustment ₹27 Cr₹25 Cr₹22 Cr₹22 Cr₹17 Cr
Changes In working Capital ₹-1.64 Cr₹-7.49 Cr₹-4.04 Cr₹-28 Cr₹1.66 Cr
Cash Flow after changes in Working Capital ₹31 Cr₹22 Cr₹27 Cr₹-1.03 Cr₹28 Cr
Cash Flow from Operating Activities ₹31 Cr₹20 Cr₹23 Cr₹-1.54 Cr₹27 Cr
Cash Flow from Investing Activities ₹-21 Cr₹-15 Cr₹-19 Cr₹-22 Cr₹-9.48 Cr
Cash Flow from Financing Activities ₹-9.59 Cr₹-7.84 Cr₹-1.21 Cr₹24 Cr₹-17 Cr
Net Cash Inflow / Outflow ₹0.55 Cr₹-2.44 Cr₹2.71 Cr₹0.37 Cr₹0.09 Cr
Opening Cash & Cash Equivalents ₹1.75 Cr₹4.20 Cr₹1.49 Cr₹1.11 Cr₹1.02 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹2.30 Cr₹1.75 Cr₹4.20 Cr₹1.49 Cr₹1.11 Cr

Compare Cashflow Statement of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹139.8 Cr 2.6% -11.8% 10% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹448,688.0 Cr -2% 6% 9.6% Stock Analytics
DIVIS LABORATORIES ₹295,080.0 Cr -4% 22.9% 75.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,677.0 Cr -1.8% 1.8% 21.9% Stock Analytics
DR REDDYS LABORATORIES ₹115,852.0 Cr -0.4% 13.1% 13.7% Stock Analytics
CIPLA ₹111,731.0 Cr -0.9% 4.5% -8% Stock Analytics


BAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

2.6%

-11.8%

10%

SENSEX

1.8%

11.1%

-1.6%


You may also like the below Video Courses